168 related articles for article (PubMed ID: 10228904)
1. The role of CA 125 in screening for ovarian cancer.
Rosenthal AN; Jacobs IJ
Int J Biol Markers; 1998; 13(4):216-20. PubMed ID: 10228904
[TBL] [Abstract][Full Text] [Related]
2. The value of ovarian cancer screening.
Sharma A; Menon U
Br J Hosp Med (Lond); 2006 Jun; 67(6):314-7. PubMed ID: 16821742
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Menon U; Gentry-Maharaj A; Hallett R; Ryan A; Burnell M; Sharma A; Lewis S; Davies S; Philpott S; Lopes A; Godfrey K; Oram D; Herod J; Williamson K; Seif MW; Scott I; Mould T; Woolas R; Murdoch J; Dobbs S; Amso NN; Leeson S; Cruickshank D; McGuire A; Campbell S; Fallowfield L; Singh N; Dawnay A; Skates SJ; Parmar M; Jacobs I
Lancet Oncol; 2009 Apr; 10(4):327-40. PubMed ID: 19282241
[TBL] [Abstract][Full Text] [Related]
4. Screening for ovarian cancer.
MacDonald ND; Rosenthal AN; Jacobs IJ
Ann Acad Med Singap; 1998 Sep; 27(5):676-82. PubMed ID: 9919339
[TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer screening: Current status and future directions.
Nash Z; Menon U
Best Pract Res Clin Obstet Gynaecol; 2020 May; 65():32-45. PubMed ID: 32273169
[TBL] [Abstract][Full Text] [Related]
6. Status of tumor markers in ovarian cancer screening.
Bast RC
J Clin Oncol; 2003 May; 21(10 Suppl):200s-205s. PubMed ID: 12743135
[TBL] [Abstract][Full Text] [Related]
7. Ovarian cancer screening-ultrasound; impact on ovarian cancer mortality.
Kamal R; Hamed S; Mansour S; Mounir Y; Abdel Sallam S
Br J Radiol; 2018 Oct; 91(1090):20170571. PubMed ID: 30102555
[TBL] [Abstract][Full Text] [Related]
8. Screening for ovarian cancer: a systematic review.
Bell R; Petticrew M; Luengo S; Sheldon TA
Health Technol Assess; 1998; 2(2):i-iv, 1-84. PubMed ID: 9561894
[No Abstract] [Full Text] [Related]
9. Calculation of the risk of ovarian cancer from serial CA-125 values for preclinical detection in postmenopausal women.
Skates SJ; Menon U; MacDonald N; Rosenthal AN; Oram DH; Knapp RC; Jacobs IJ
J Clin Oncol; 2003 May; 21(10 Suppl):206s-210s. PubMed ID: 12743136
[TBL] [Abstract][Full Text] [Related]
10. Screening for ovarian cancer.
Quinn MA
Aust Fam Physician; 2001 Jun; 30(6):530-4. PubMed ID: 11458578
[TBL] [Abstract][Full Text] [Related]
11. Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project.
Gilbert L; Basso O; Sampalis J; Karp I; Martins C; Feng J; Piedimonte S; Quintal L; Ramanakumar AV; Takefman J; Grigorie MS; Artho G; Krishnamurthy S;
Lancet Oncol; 2012 Mar; 13(3):285-91. PubMed ID: 22257524
[TBL] [Abstract][Full Text] [Related]
12. Screening for ovarian cancer: a pilot randomised controlled trial.
Jacobs IJ; Skates SJ; MacDonald N; Menon U; Rosenthal AN; Davies AP; Woolas R; Jeyarajah AR; Sibley K; Lowe DG; Oram DH
Lancet; 1999 Apr; 353(9160):1207-10. PubMed ID: 10217079
[TBL] [Abstract][Full Text] [Related]
13. Screening for Ovarian Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Henderson JT; Webber EM; Sawaya GF
JAMA; 2018 Feb; 319(6):595-606. PubMed ID: 29450530
[TBL] [Abstract][Full Text] [Related]
14. Estimating Cost-effectiveness of a Multimodal Ovarian Cancer Screening Program in the United States: Secondary Analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Moss HA; Berchuck A; Neely ML; Myers ER; Havrilesky LJ
JAMA Oncol; 2018 Feb; 4(2):190-195. PubMed ID: 29222541
[TBL] [Abstract][Full Text] [Related]
15. Ovarian cancer screening.
Alexander-Sefre F; Menon U; Jacobs IJ
Hosp Med; 2002 Apr; 63(4):210-3. PubMed ID: 11995270
[TBL] [Abstract][Full Text] [Related]
16. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Menon U; Gentry-Maharaj A; Burnell M; Singh N; Ryan A; Karpinskyj C; Carlino G; Taylor J; Massingham SK; Raikou M; Kalsi JK; Woolas R; Manchanda R; Arora R; Casey L; Dawnay A; Dobbs S; Leeson S; Mould T; Seif MW; Sharma A; Williamson K; Liu Y; Fallowfield L; McGuire AJ; Campbell S; Skates SJ; Jacobs IJ; Parmar M
Lancet; 2021 Jun; 397(10290):2182-2193. PubMed ID: 33991479
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of ovarian cancer among women with a CA125 level of 35 U/ml or less.
Kobayashi H; Yamada Y; Sado T; Sakata M; Yoshida S; Kawaguchi R; Kanayama S; Shigetomi H; Haruta S; Tsuji Y; Ueda S; Kitanaka T; Oi H
Gynecol Obstet Invest; 2008; 65(2):133-8. PubMed ID: 17957102
[TBL] [Abstract][Full Text] [Related]
18. Ovarian cancer screening. The use of serial complementary tumor markers to improve sensitivity and specificity for early detection.
Berek JS; Bast RC
Cancer; 1995 Nov; 76(10 Suppl):2092-6. PubMed ID: 8635006
[TBL] [Abstract][Full Text] [Related]
19. Screening for ovarian cancer in the general population.
Chu CS; Rubin SC
Best Pract Res Clin Obstet Gynaecol; 2006 Apr; 20(2):307-20. PubMed ID: 16364690
[TBL] [Abstract][Full Text] [Related]
20. Screening for ovarian cancer.
Anderiesz C; Quinn MA
Med J Aust; 2003 Jun; 178(12):655-6. PubMed ID: 12797860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
